MyJournals Home  

RSS FeedsApprovals in 2018: a histology-agnostic new molecular entity, novel end points and real-time review (Nature Clinical Practice Oncology)

 
 

22 january 2019 21:01:16

 
Approvals in 2018: a histology-agnostic new molecular entity, novel end points and real-time review (Nature Clinical Practice Oncology)
 




 
62 viewsCategory: Oncology
 
Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2 (Oncogene)
CRISPR-Cas: a tool for cancer research and therapeutics (Nature Clinical Practice Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten